CAMBRIDGE, Mass., Jun 12, 2003 (BUSINESS WIRE) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its Analyst and Investor Day presentations will be webcast live on the investor relations section of its website at www.alkermes.com.
Alkermes senior management will review the Company's business strategy, pipeline progress and drug development operations. The presentations will be delivered on Thursday, June 19, 2003 beginning at approximately 12:30pm EDT and ending at 3:30pm EDT from the Waldorf Astoria Hotel in New York City. This webcast will be archived for 30 days.
Alkermes, Inc. is an emerging pharmaceutical company developing products based on its sophisticated drug delivery technologies to enhance therapeutic outcomes. Our areas of focus include: controlled, extended-release of injectable drugs utilizing our ProLease(R) and Medisorb(R) delivery systems and the development of inhaled pharmaceutical products based on our proprietary Advanced Inhalation Research, Inc. ("AIR(R)") pulmonary delivery system. Our business strategy is twofold. We partner our proprietary technology systems and drug delivery expertise with many of the world's finest pharmaceutical companies and also develop novel, proprietary drug candidates for our own account. In addition to our Cambridge, Massachusetts headquarters, research and manufacturing facilities, we operate research and manufacturing facilities in Ohio.
SOURCE: Alkermes, Inc.
Alkermes, Inc.
Director, Corporate Communications
Rebecca Peterson, 617/583-6378